Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

AnaptysBio, Inc. (ANAB) vs Immunocore Holdings PLC Sponsored ADR (IMCR)

AnaptysBio, Inc. and Immunocore Holdings PLC Sponsored ADR are both Biotechnology companies. AnaptysBio, Inc. and Immunocore Holdings PLC Sponsored ADR are of similar size ($1.6B and $1.6B). AnaptysBio, Inc. grew revenue faster over the last twelve months: 107.7% against 21.0%. Immunocore Holdings PLC Sponsored ADR has the higher net margin (−4.20% vs −11.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, AnaptysBio, Inc. leads on 9 and Immunocore Holdings PLC Sponsored ADR on 8.

Valuation

Metric ANAB IMCR Biotechnology median
P/E n/m n/m 7.88
P/S 6.30 3.64 11.47
P/B 114.79 3.73 2.52
Price to free cash flow 331.88 n/m 21.16
EV/EBITDA 37.47 n/m 0.74
EV/Sales 6.47 2.62 10.73
Earnings yield (1.67%) (1.17%) (28.84%)
Free cash flow yield 0.30% (2.63%) (23.03%)

Profitability

Metric ANAB IMCR Biotechnology median
Gross margin 100.00% 98.90% 65.16%
Operating margin 17.56% (5.24%) 0.00%
Net margin (11.53%) (4.20%) 0.00%
Free cash flow margin 1.90% (9.55%) 0.00%
Return on equity (114.55%) (4.47%) (57.72%)
Return on assets (7.13%) (1.64%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANAB IMCR Biotechnology median
Revenue growth (TTM) 107.73% 20.95% 5.64%
EPS growth (last fiscal year) 91.02% 30.39% —
Revenue growth, 5-year CAGR 25.62% 59.57% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANAB IMCR Biotechnology median
Debt to equity 0.00 0.94 0.00
Current ratio 7.58 4.47 4.73
Net debt to EBITDA (6.84) 11.19 0.96

Dividend

Metric ANAB IMCR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ANAB IMCR Biotechnology median
Market cap 1.55b 1.61b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack